With the steep rise in Hospital acquired infections (HAI) in the count...
Pharma major Lupin Limited (Lupin) announced the launch of Clobazam Ta...
Novartis has entered into an agreement with Takeda Pharmaceutical Comp...
In a recent Italian study published in the International Journal of Me...
Apollo Hospital, Sheshadripuram, one of the premier multispecialty hos...
Adding 10,000 new Thalassemic Major and an equal number of Thalassemia...
Pall Biotech is organizing a one day training on the challenges of exp...
Columbia Asia Hospital Hebbal organized a week-long free lung screenin...
Atelerix, creator of an innovative cell encapsulation technology,...
Lupin Limited (Lupin) and Aptissen S.A. (Aptissen) announced that they...
AM Foundation, the CSR arm of AM International, Singapore conduct...
The Diabetes Care Devices Market is set to grow from its current marke...
Paras HMRI hospital, Raja Bazaar, Patna has made arrangements to provi...
Pfizer has announced that it has entered into a definitive agreement t...
Malaria is a known potentially fatal disease that is caused due to a s...
Technology is increasing the control that individuals have over their ...
Glenmark Pharmaceuticals has announced positive results from a Phase 3...
India reports an average of 10,000* children born with Thalassemia maj...
